Insiders the Biggest Winners as IVD Medical Holding Limited's (HKG:1931) Market Cap Rises to HK$1.8b
Insiders the Biggest Winners as IVD Medical Holding Limited's (HKG:1931) Market Cap Rises to HK$1.8b
Key Insights
主要见解
- Insiders appear to have a vested interest in IVD Medical Holding's growth, as seen by their sizeable ownership
- A total of 4 investors have a majority stake in the company with 57% ownership
- Using data from company's past performance alongside ownership research, one can better assess the future performance of a company
- 内部人似乎对华检医疗控股的增长有着特殊利益,这可以从他们持有的大量股份来看
- 有4家投资者持有中国渤海银行超过57%的股份。
- 通过公司过去的业绩数据和股权研究,人们可以更好地评估一家公司的未来表现。
If you want to know who really controls IVD Medical Holding Limited (HKG:1931), then you'll have to look at the makeup of its share registry. And the group that holds the biggest piece of the pie are individual insiders with 37% ownership. Put another way, the group faces the maximum upside potential (or downside risk).
如果你想知道谁真正控制着华检医疗控股有限公司(HKG:1931),那就得看看其股东名册构成。而拥有最大股份的是个人内部人员,占据了37%的所有权。换句话说,该集团面临着最大的上涨潜力(或下跌风险)。
Clearly, insiders benefitted the most after the company's market cap rose by HK$585m last week.
很明显,在上周公司市值上涨了58500万港元后,内部人员受益最多。
Let's take a closer look to see what the different types of shareholders can tell us about IVD Medical Holding.
让我们仔细观察不同类型股东对华检医疗控股有何提示。
What Does The Institutional Ownership Tell Us About IVD Medical Holding?
机构所有权告诉我们什么关于华检医疗控股?
Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.
机构投资者通常将自己的回报与常见的指数回报进行比较。因此,他们通常会考虑购买包括在相关基准指数中的较大公司。
We can see that IVD Medical Holding does have institutional investors; and they hold a good portion of the company's stock. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of IVD Medical Holding, (below). Of course, keep in mind that there are other factors to consider, too.
我们可以看到,华检医疗控股确实有机构投资者,他们持有公司股份的很大一部分。这表明在专业投资者中有一定的信誉。但我们不能仅仅依靠这个事实,因为机构有时也会做出糟糕的投资,就像每个人一样。如果两个大的机构投资者同时试图抛售股票,股价大幅下跌也是很常见的情况。所以值得检查华检医疗控股的过去收益轨迹(下文)。当然,还要考虑其他因素。
IVD Medical Holding is not owned by hedge funds. Our data shows that Shinva Medical Instrument Co.,Ltd. is the largest shareholder with 27% of shares outstanding. The second and third largest shareholders are King Sun Leung and Kuk Sing Ho, with an equal amount of shares to their name at 11%. Kuk Sing Ho, who is the third-largest shareholder, also happens to hold the title of Chairman of the Board.
华检医疗控股不是由对冲基金持有。我们的数据显示,新华医疗器械股份有限公司是最大的股东,持有27%的股份。第二和第三大股东分别是金新良和曲星灏,他们各自拥有11%的股份。曲星灏是第三大股东,也是董事会主席。
To make our study more interesting, we found that the top 4 shareholders control more than half of the company which implies that this group has considerable sway over the company's decision-making.
为了使我们的研究更有趣,我们发现前四名股东控制了公司一半以上的股份,这意味着该集团对公司的决策具有相当大的影响力。
While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. We're not picking up on any analyst coverage of the stock at the moment, so the company is unlikely to be widely held.
研究公司的机构所有权可以为您的研究增加价值,但同时调查分析师建议也是很好的做法,以更深入地了解股票的预期表现。我们目前没有发现任何关于该公司的分析师报道,因此该公司不太可能被广泛持有。
Insider Ownership Of IVD Medical Holding
华检医疗控股的内部所有权
While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.
虽然内部人员的具体定义可能是主观的,但几乎所有人都认为董事会成员是内部人员。公司管理层应向董事会回答问题,后者应代表股东的利益。值得注意的是,有时高层管理人员也会成为董事会成员。
I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.
我通常认为内部人士持股是一件好事。但是,在某些情况下,它会使其他股东更难以对董事会的决定进行问责。
Our information suggests that insiders maintain a significant holding in IVD Medical Holding Limited. It has a market capitalization of just HK$1.8b, and insiders have HK$643m worth of shares in their own names. We would say this shows alignment with shareholders, but it is worth noting that the company is still quite small; some insiders may have founded the business. You can click here to see if those insiders have been buying or selling.
我们的信息表明,内部人士在华检医疗控股有限公司持有大量股份。其市值仅为18亿港元,内部人士名下持有64300万港元的股票。我们认为这显示出与股东的一致,但值得注意的是公司仍然相当小;一些内部人士可能创立了这家业务。您可以 点击这里 查看这些内部人士是在买入还是卖出。
General Public Ownership
一般大众所有权
The general public, who are usually individual investors, hold a 28% stake in IVD Medical Holding. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.
普通投资者,通常是个人投资者,在华检医疗控股有28%的股权。虽然这一群体可能不能决定事情的走向,但他们肯定会对公司的运作产生真正的影响。
Public Company Ownership
上市公司所有权
Public companies currently own 27% of IVD Medical Holding stock. We can't be certain but it is quite possible this is a strategic stake. The businesses may be similar, or work together.
目前,公开公司占IVD医疗控股股票的27%。我们不能确定,但这很可能是战略股权。这些企业可能相似或共同工作。
Next Steps:
下一步:
It's always worth thinking about the different groups who own shares in a company. But to understand IVD Medical Holding better, we need to consider many other factors. For example, we've discovered 2 warning signs for IVD Medical Holding (1 doesn't sit too well with us!) that you should be aware of before investing here.
考虑到拥有公司股票的不同群体总是值得思考的。但是为了更好地理解IVD医疗控股,我们还需要考虑许多其他因素。例如,我们已经发现IVD医疗控股存在2个警告信号(其中1个对我们来说不太好!)在投资此处之前,您应该对此有所了解。
Of course this may not be the best stock to buy. Therefore, you may wish to see our free collection of interesting prospects boasting favorable financials.
当然,这也可能不是最好的股票交易。因此,您可能想看看我们免费的潜力股票收藏,这些股票具有有利的财务状况。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注:本文中的数据是使用最后一个财务报表日期结束的为期12个月的数据计算的。这可能与全年年度报告数据不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。